Clinical Trials in Jinzhong, Shanxi
5 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Extensive-stage Small-cell Lung Cancer
Second Hospital of Shanxi Medical University40 enrolled6 locationsNCT06536868
Recruiting
Phase 3
Normobaric Oxygen in AIS Transferred for EVT
Ischemic Stroke
Capital Medical University1,500 enrolled112 locationsNCT06666764
Recruiting
Phase 3
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC
NSCLCRadiation PneumonitisNintedanib
Second Hospital of Shanxi Medical University40 enrolled7 locationsNCT06570317